15 Recruiting Trials

Clinical Trials for Lupus in Louisiana

15 clinical trials for Lupus are currently recruiting participants at study sites in Louisiana. Study-related care is provided at no cost.

Showing 15 of 15 recruiting Lupus trials in Louisiana

Recruiting
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
PHASE1 Little Rock, Arkansas +4 sites NCT06557265
Recruiting
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
PHASE2 Fresno, California +4 sites NCT06559163
Recruiting
Recruiting

Lupus clinical trials in Louisiana: common questions

How many Lupus clinical trials are recruiting in Louisiana?
TrialFinder currently lists 15 recruiting Lupus clinical trials with study sites in Louisiana. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Lupus clinical trials located in Louisiana?
Study sites for the Lupus trials listed on this page include New Orleans. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Lupus clinical trial in Louisiana?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Lupus trials in Louisiana also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Lupus clinical trial in Louisiana?
Each study sets its own criteria based on age, Lupus diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Lupus trials near you in Louisiana.

Get Matched — Free
No insurance required

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

All Lupus trials →